SpringWorks Therapeutics, Inc. (SWTX)

SpringWorks Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	118.65	176.67	68.07	104.53	147.65	328.19
Short-Term Investments	318.55	303.15	524.72	269.54	361.4	0
Cash & Cash Equivalents	437.2	479.82	592.79	374.07	509.05	328.19
Cash Growth	-17.31%	-19.06%	58.47%	-26.52%	55.11%	610.56%
Receivables	15.53	5.93	0	0	0	0
Inventory	5.22	3.1	0	0	0	0
Other Current Assets	13.85	12.06	6.97	8.84	4.35	3.17
Total Current Assets	471.8	500.91	599.76	382.91	513.4	331.36
Property, Plant & Equipment	24.08	24.09	18.27	4.2	3.02	0.8
Long-Term Investments	145.57	185.34	8.99	62.11	57.21	0.98
Other Long-Term Assets	15.39	15.45	3.23	3.27	2.57	1.7
Total Long-Term Assets	185.03	224.88	30.48	69.58	62.79	3.47
Total Assets	656.83	725.79	630.24	452.49	576.19	334.83
Accounts Payable	7.01	7.4	8.01	3.43	1.35	2.65
Deferred Revenue	19.55	19.55	19.55	0	0	0
Current Debt	0.98	1.06	0.48	1.16	1.38	0
Other Current Liabilities	41.38	50.17	23.01	25.38	14.89	9.32
Total Current Liabilities	68.92	78.17	51.05	29.97	17.61	11.97
Long-Term Debt	5.58	6	4.77	0.13	1.36	0
Other Long-Term Liabilities	14.89	15.4	16.23	0	0.16	0.79
Total Long-Term Liabilities	20.48	21.4	21	0.13	1.52	0.79
Total Liabilities	89.39	99.57	72.05	30.1	19.13	12.76
Total Debt	6.56	7.06	5.25	1.29	2.73	0
Debt Growth	-6.92%	34.39%	306.74%	-52.78%	-	-
Retained Earnings	-982.42	-895.03	-569.93	-292.51	-118.6	-73.03
Comprehensive Income	-0.11	1.19	-0.77	-0.31	0.04	0
Shareholders' Equity	567.44	626.22	558.19	422.4	557.06	322.07
Net Cash / Debt	430.64	472.76	587.54	372.78	506.32	328.19
Net Cash / Debt Growth	-17.45%	-19.54%	57.61%	-26.37%	54.27%	610.56%
Net Cash Per Share	5.84	7.49	11.03	7.69	11.69	24.72
Working Capital	402.88	422.74	548.71	352.94	495.79	319.39
Book Value Per Share	7.69	9.92	10.47	8.71	12.87	24.26

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).